Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study

<p dir="ltr">The currently authorized mRNA COVID-19 vaccines, Pfizer-BNT162b2 and Moderna-mRNA-1273, offer great promise for reducing the spread of the COVID-19 by generating protective immunity against SARS-CoV-2. Recently, it was shown that the magnitude of the neutralizing antibod...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Farah M. Shurrab (16324961) (author)
مؤلفون آخرون:	Duaa W. Al-Sadeq (10976754) (author), Haissam Abou-Saleh (497840) (author), Nader Al-Dewik (4166527) (author), Amira E. Elsharafi (18300841) (author), Fatima M. Hamaydeh (18300844) (author), Bushra Y. Abo Halawa (18300847) (author), Tala M. Jamaleddin (18300850) (author), Huda M. Abdul Hameed (18300853) (author), Parveen B. Nizamuddin (14590613) (author), Fathima Humaira Amanullah (18300856) (author), Hanin I. Daas (17863886) (author), Laith J. Abu-Raddad (9262524) (author), Gheyath K. Nasrallah (9200525) (author)
منشور في:	2022
الموضوعات:	Biomedical and clinical sciences Immunology Pharmacology and pharmaceutical sciences neutralizing antibodies Pfizer-BNT162b2 Moderna-mRNA-1273 SARS-CoV-2 vaccine
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study

مواد مشابهة